Biao Lu

Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV

Joel E. Gallant, Edwin DeJesus, José Ramón Arribas et al. · New England Journal of Medicine · 2006 · 886 citations

Medicine, Pharmacokinetics, Pharmacology +12

Efficacy of Tenofovir Disoproxil Fumarate in Antiretroviral Therapy–Naive and –Experienced Patients Coinfected with HIV‐1 and Hepatitis B Virus

Gregory J. Dore, David A. Cooper, Anton Pozniak et al. · The Journal of Infectious Diseases · 2004 · 254 citations

Medicine, Infectious Diseases, Pharmacology +17

Genotypic and Phenotypic Predictors of the Magnitude of Response to Tenofovir Disoproxil Fumarate Treatment in Antiretroviral‐Experienced Patients

Michael D. Miller, Nicolas Margot, Biao Lu et al. · The Journal of Infectious Diseases · 2004 · 212 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1

Yves Benhamou, Vincent Thibault, Pamela Vig et al. · Journal of Hepatology · 2005 · 81 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients

Joel E. Gallant, Schlomo Staszewski, Anton Pozniak et al. · 2004 · 61 citations

Medicine, Pharmacokinetics, Pharmacology +15